A

Development and validation of a pathomics-driven machine learning model for individualized prediction of neoadjuvant chemotherapy response and early recurrence in HR-positive, HER2-negative breast cancer

Frontiers in Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 2

References 1

1 result